HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Show What’s Inside”: Seventh Generation Joins Ingredient Disclosure Debate

This article was originally published in The Rose Sheet

Executive Summary

Eco-friendly consumer products firm Seventh Generation says it’s time for firms to disclose fragrance ingredients so that consumers can make informed decisions as to the products they purchase.

You may also be interested in...



Women’s Voices Join In Fragrance Disclosure Debate, Citing Allergy Risks

NGO Women’s Voices for the Earth says the rising incidence of fragrance allergy worldwide points to a need for fragrance ingredient disclosure. In an online petition, the group is calling on IFRA to establish “an industry-wide policy” of full transparency so consumers can make informed choices about fragranced product use.

Reckitt Benckiser Sustainability Plan Sets Innovation, Transparency Goals

The marketer of Mucinex decongestants integrates a “better design” component into its “betterbusiness” sustainability plan with the goal of deriving one-third of its net revenue from more sustainable products by 2020. The firm also targets “100% transparency on ingredients.”

Reckitt Benckiser Sustainability Plan Sets Innovation, Transparency Goals

The marketer of Mucinex decongestants integrates a “better design” component into its “betterbusiness” sustainability plan with the goal of deriving one-third of its net revenue from more sustainable products by 2020. The firm also targets “100% transparency on ingredients.”

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017862

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel